Synergy between Toxoplasma gondii type I ΔGRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors
Guardado en:
Autores principales: | Jia Chen, Yu-Chao Zhu, Hany M Elsheikha, Jian-Hua Wang, Shuai Fang, Jun-Jun He, Xing-Quan Zhu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3154ce45d4f44467bc3c77641cdf324d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PD-1 checkpoint blockade enhances adoptive immunotherapy by human Vγ2Vδ2 T cells against human prostate cancer
por: Mohanad H. Nada, et al.
Publicado: (2021) -
Differential Impacts on Host Transcription by ROP and GRA Effectors from the Intracellular Parasite <named-content content-type="genus-species">Toxoplasma gondii</named-content>
por: Suchita Rastogi, et al.
Publicado: (2020) -
Human Innate Immunity to <named-content content-type="genus-species">Toxoplasma gondii</named-content> Is Mediated by Host Caspase-1 and ASC and Parasite GRA15
por: Lanny Gov, et al.
Publicado: (2013) -
<italic toggle="yes">Toxoplasma</italic> Uses GRA16 To Upregulate Host c-Myc
por: Michael W. Panas, et al.
Publicado: (2020) -
Detection of Toxoplasma gondii in swine sausages
por: DE OLIVEIRA MENDONÇA,ANDRÉ, et al.
Publicado: (2004)